Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS)

Xavier Poiré, Carlos Graux, Aurélie Ory, Julie Herman, Frédéric Baron, Hélène Schoemans, Philippe Lewalle, Ann De Becker, Dries Deeren, Zwi Berneman, Tessa Kerre, Pierre Zachée, Dominik Selleslag, Yves Béguin